Sökning: "allogeneic stem cell transplantation"

Visar resultat 16 - 20 av 97 avhandlingar innehållade orden allogeneic stem cell transplantation.

1. 16. Neurological complications after stem cell transplantation in children

   Författare :Johanna Rubin; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Allogeneic haematopoietic stem cell transplantation (HSCT) is a well established method used in the treatment of a number of benign and malignant blood diseases, inborn errors of metabolism and severe congenital immunodeficiency syndromes. Around 60 children are transplanted in Sweden every year. LÄS MER

3. 17. New strategies for allogeneic hematopoietic stem cell transplantation with umbilical cord

   Författare :Jens Gertow; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Umbilical cord blood is enriched in hematopoietic stem cells. For this reason, cord blood units may be utilized for allogeneic hematopoietic stem cell transplantations when no adult human leukocyte antigen (HLA)‐matched donor is found. LÄS MER

4. 18. HLA and KIR gene polymorphism in hematopoietic stem cell transplantation

   Författare :Marie Schaffer; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :HLA; KIR; NK cells; hematopoietic stem cell transplantation; unrelated donor;

   Sammanfattning : The major histocompatibility complex (MHC) in humans known as the Human Leukocyte Antigens (HLA) is localised to the short arm of chromosome six. The HLA class 1 antigens, HLA-A, -B and -C are highly polymorphic glycoproteins expressed on the cell surface of most nucleated cells in the body. LÄS MER

5. 19. Stem cell transplantation : home care, graft-versus-host disease and costs

   Författare :Britt-Marie Svahn; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :Stem-cell transplantation; home-care; GVHD; costs;

   Sammanfattning : Allogeneic stem-cell transplantation (ASCT) is used to treat malignant and non-malignant diseases of the immunohematopoietic system. Results in terms of survival rate and less complications are continually improving due to better knowledge, supportive care, immunosuppression, new drugs against infections and HLA-typing techniques. LÄS MER

7. 20. The methodology and significance of minimal residual disease detection after allogeneic stem cell transplantation

   Författare :Mehmet Uzunel; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :Minimal Residual Disease; Stem Cell Transplantation; ALL; AML; CML; Relapse;

   Sammanfattning : Allogeneic stem cell transplantation (SCT) is the choice of therapy for leukemia patients who respond poorly to conventional chemotherapy. Despite high remission rates after SCT, relapse of the underlying disease remains one of the most frequent causes of treatment failure. LÄS MER